The drug industry is facing one of the largest patent cliffs in recent history. Will that mean dealmaking at the annual J.P.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

Merck and Pfizer are to take on the crowded SGLT2 inhibitor market with a keenly-priced new contender. The FDA approved Steglatro (ertugliflozin) as a monotherapy in conjunction with diet and ...

A more potent GLP-1 drug, it has shown superior results to Jardiance in cutting heart attacks ... Saxenda (Victoza under a different dose and brand name), which Maziar Mike Doustdar says is ...

People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...

On the eve of its 25th anniversary, Takeshi gave his company a shorter name: Onkyo. The Onkyo brand is part of the Premium Audio Company alongside sister brands like Klipsch and Jamo. The word ...

Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...

Brand New reunited over the weekend nearly seven years after the band split up for a secret performance in Nashville, as confirmed by Lambgoat. Reports surfaced over the last few days that the ...